Financial reports
10-Q
2014 Q2
Quarterly report
31 Jul 14
ARS
2013 FY
Annual report to shareholders
5 May 14
10-Q
2014 Q1
Quarterly report
1 May 14
10-K
2013 FY
Annual report
27 Feb 14
10-Q
2013 Q3
Quarterly report
30 Oct 13
10-Q
2013 Q2
Quarterly report
7 Aug 13
10-Q
2013 Q1
Quarterly report
30 Apr 13
ARS
2012 FY
Annual report to shareholders
26 Apr 13
10-K
2012 FY
Annual report
25 Feb 13
10-Q
2012 Q3
Quarterly report
1 Nov 12
Current reports
8-K
Completion of Acquisition or Disposition of Assets
5 Aug 14
8-K
Second Quarter and Six Month 2014 Financial Results
31 Jul 14
8-K
Departure of Directors or Certain Officers
17 Jun 14
8-K
Entry into a Material Definitive Agreement
9 Jun 14
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 14
8-K
First Quarter 2014 Financial Results and HCV Pipeline Review
1 May 14
8-K
Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide
7 Apr 14
8-K
Departure of Directors or Certain Officers
3 Apr 14
8-K
Other Events
24 Mar 14
8-K
Idenix Pharmaceuticals Files Patent Infringement
14 Mar 14
Registration and prospectus
15-12G
Securities registration termination
15 Aug 14
SC TO-T/A
Third party tender offer statement (amended)
6 Aug 14
25-NSE
Exchange delisting
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Aug 14
SC 14D9/A
Tender offer solicitation (amended)
5 Aug 14
Proxies
DEF 14A
Definitive proxy
29 Apr 14
DEF 14A
Definitive proxy
26 Apr 13
DEF 14A
Definitive proxy
25 Apr 12
DEF 14A
Definitive proxy
25 Apr 11
PRE 14A
Preliminary proxy
8 Apr 11
DEF 14A
Definitive proxy
30 Apr 10
DEF 14A
Definitive proxy
28 Apr 09
DEF 14A
Definitive proxy
25 Apr 08
DEF 14A
Definitive proxy
26 Apr 07
PRE 14A
Preliminary proxy
11 Apr 07
Other
EFFECT
Notice of effectiveness
2 May 14
CORRESP
Correspondence with SEC
30 Apr 14
CT ORDER
Confidential treatment order
11 Mar 14
UPLOAD
Letter from SEC
6 Mar 14
CT ORDER
Confidential treatment order
29 Aug 13
CT ORDER
Confidential treatment order
21 Mar 13
CT ORDER
Confidential treatment order
21 Mar 13
CT ORDER
Confidential treatment order
8 Feb 13
CT ORDER
Confidential treatment order
20 Sep 12
CT ORDER
Confidential treatment order
28 Aug 12
Ownership
SC 13D/A
Idenix Pharmaceuticals Inc
12 Aug 14
SC 13D/A
Idenix Pharmaceuticals Inc
12 Aug 14
SC 13D/A
Idenix Pharmaceuticals Inc
29 Jul 14
SC 13D
Idenix Pharmaceuticals Inc
13 Jun 14
SC 13D/A
Idenix Pharmaceuticals Inc
3 Apr 14
SC 13D/A
Idenix Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Idenix Pharmaceuticals Inc
12 Feb 14
SC 13G/A
Idenix Pharmaceuticals Inc
11 Feb 14
SC 13G/A
Idenix Pharmaceuticals Inc
7 Feb 14
SC 13D/A
Idenix Pharmaceuticals Inc
4 Feb 14